UBS Group AG boosted its holdings in Molina Healthcare, Inc. (NYSE:MOH – Get Rating) by 11.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 41,432 shares of the company’s stock after purchasing an additional 4,267 shares during the period. UBS Group AG’s holdings in Molina Healthcare were worth $13,682,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently added to or reduced their stakes in the business. Cambridge Investment Research Advisors Inc. increased its position in Molina Healthcare by 18.9% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 1,404 shares of the company’s stock worth $464,000 after buying an additional 223 shares during the period. California Public Employees Retirement System grew its holdings in shares of Molina Healthcare by 76.3% during the 4th quarter. California Public Employees Retirement System now owns 229,998 shares of the company’s stock worth $75,950,000 after purchasing an additional 99,541 shares in the last quarter. Nordea Investment Management AB grew its holdings in shares of Molina Healthcare by 106.3% during the 4th quarter. Nordea Investment Management AB now owns 7,288 shares of the company’s stock worth $2,405,000 after purchasing an additional 3,755 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Molina Healthcare by 6.7% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,308 shares of the company’s stock worth $762,000 after purchasing an additional 145 shares in the last quarter. Finally, Arizona State Retirement System grew its holdings in shares of Molina Healthcare by 2.0% during the 4th quarter. Arizona State Retirement System now owns 16,445 shares of the company’s stock worth $5,430,000 after purchasing an additional 328 shares in the last quarter. 94.25% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
MOH has been the topic of several recent research reports. Credit Suisse Group lifted their price objective on Molina Healthcare from $347.00 to $350.00 in a report on Friday, April 28th. Truist Financial decreased their price target on Molina Healthcare from $400.00 to $380.00 and set a “buy” rating on the stock in a research note on Friday, February 10th. Stephens reaffirmed an “equal weight” rating and issued a $375.00 price target on shares of Molina Healthcare in a research note on Thursday, February 9th. JPMorgan Chase & Co. decreased their price target on Molina Healthcare from $360.00 to $348.00 and set an “overweight” rating on the stock in a research note on Thursday, February 23rd. Finally, Cantor Fitzgerald began coverage on Molina Healthcare in a research note on Thursday, April 20th. They issued an “overweight” rating and a $354.00 price target on the stock. One research analyst has rated the stock with a sell rating, four have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Molina Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $354.75.
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Rating) last released its earnings results on Wednesday, April 26th. The company reported $5.81 earnings per share for the quarter, topping analysts’ consensus estimates of $5.13 by $0.68. The company had revenue of $8.15 billion during the quarter, compared to the consensus estimate of $8.31 billion. Molina Healthcare had a return on equity of 36.20% and a net margin of 2.64%. The firm’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.90 earnings per share. Equities research analysts forecast that Molina Healthcare, Inc. will post 20.25 earnings per share for the current fiscal year.
Insider Transactions at Molina Healthcare
In other news, Director Daniel Cooperman sold 5,000 shares of the business’s stock in a transaction on Friday, March 3rd. The stock was sold at an average price of $276.77, for a total transaction of $1,383,850.00. Following the completion of the sale, the director now owns 4,944 shares in the company, valued at $1,368,350.88. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 1.10% of the stock is currently owned by corporate insiders.
Molina Healthcare Profile
Molina Healthcare, Inc engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.
Featured Articles
- Get a free copy of the StockNews.com research report on Molina Healthcare (MOH)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Get Rating).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.